Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Filter Data

Reset All
  • Access
    PDS or NCI
    • All
    • Project Data Sphere
    • National Cancer Institute
  • Arm
    Any / All
    • All
    • Comparator Arm Only
    • Experimental Arm Only
    • Both Arms
  • Data Provider
    Any / All
    • All
    • Alliance for Clinical Trials in Oncology
    • Amgen
    • Asociación Colaboración Cochrane Iberoamericana (ACCIb)
    • AstraZeneca
    • Bayer HealthCare Pharmaceuticals Inc.
    • Brigham and Women's Hospital
    • Celgene
    • Clovis
    • EMD Serono
    • Eli Lilly
    • G1 Therapeutics, Inc.
    • Memorial Sloan Kettering Cancer Center
    • National Cancer Institute
    • Pfizer
    • RTI International
    • Researcher Curated
    • Sanofi
    • Synta
  • Sponsor
    Any / All
    • All
    • Alliance for Clinical Trials in Oncology
    • Amgen
    • Asociación Colaboración Cochrane Iberoamericana (ACCIb)
    • AstraZeneca
    • Bayer HealthCare Pharmaceuticals Inc.
    • Brigham and Women's Hospital
    • Canadian Cancer Trials Group
    • Celgene Corporation
    • Children's Oncology Group
    • Clovis Oncology
    • ECOG-ACRIN Cancer Research Group
    • EMD Serono
    • Eastern Cooperative Oncology Group
    • Eli Lilly
    • G1 Therapeutics, Inc.
    • GOG Foundation
    • Gary Morrow
    • Gynecologic Oncology Group
    • Merck KGaA
    • NCIC Clinical Trials Group
    • NRG Oncology
    • NSABP Foundation Inc
    • National Cancer Institute
    • National Cancer Institute (NCI)
    • Novacea, Inc.
    • Pfizer
    • Radiation Therapy Oncology Group
    • Researcher Curated
    • SWOG Cancer Research Network
    • Sanofi US Services Inc.
    • Southwest Oncology Group
    • Supriya Mohile
    • Synta Pharmaceuticals
    • Wake Forest University Health Sciences
  • Study Phase
    Any / All
    • All
    • Phase 2B
    • Phase 3
  • Tumor Type
    Any / All
    • All
    • Bladder
    • Breast
    • CNS
    • Colorectal
    • Esophageal
    • Eye
    • Gastrointestinal
    • Germ Cell
    • Head and Neck
    • Kidney
    • Leukemia/Lymphoma
    • Liver
    • Lung
    • Melanoma
    • Multiple
    • Neuroblastoma
    • Neuroendocrine
    • Other
    • Ovarian
    • Pancreas
    • Prostate
    • Sarcoma
    • Uterine
  • Linked Data
    Any / All
    • All
    • MEPS
    • Data Challenge
252 Studies | All Studies
  • Sort: Most Recent
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    June 2007
    NCT00085124Uploaded 05-25-2024
    Access via NCI by Request
    A Phase III Study of Daunorubicin and Cytarabine +/- G3139 (Genasense, Oblimersen Sodium, NSC #683428, IND #58842), a BCL2 Antisense Oligodeoxynucleotide, in Previously Untreated Patients With Acute Myeloid Leukemia (AML) > / = 60 Years
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    July 2018
    NCT00567580Uploaded 05-07-2024
    Access via NCI by Request
    A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy
    Type(s) of Cancer
    Gestational Trophoblastic Tumor
    Study Phase
    Phase 3
    Study Completion Date
    May 2018
    NCT01535053Uploaded 04-20-2024
    Access via NCI by Request
    A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
    Type(s) of Cancer
    Lung Cancer
    Study Phase
    Phase 3
    Study Completion Date
    March 2022
    NCT00632853Uploaded 04-20-2024
    Access via NCI by Request
    Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    February 2015
    NCT00093470Uploaded 03-19-2024
    Access via NCI by Request
    A Phase III Randomized Study of Farnesyl Transferase Inhibitor R115777 in Acute Myeloid Leukemia (AML) Patients in Second or Subsequent Remission or in Remission After Primary Induction Failure or Patients Over Age 60 in First Remission
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    March 2016
    NCT00381680Uploaded 03-05-2024
    Access via NCI by Request
    Intensive Treatment for Intermediate-Risk Relapse of Childhood B-precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies
    Type(s) of Cancer
    CNS
    Study Phase
    Phase 3
    Study Completion Date
    December 2015
    NCT00304070Uploaded 02-27-2024
    Access via NCI by Request
    Treatment of Adrenocortical Tumors With Surgery Plus Lymph Node Dissection and Multiagent Chemotherapy: A Groupwide Phase III Study
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    December 2019
    NCT03103321Uploaded 02-08-2024
    Access via NCI by Request
    Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    March 2019
    NCT01190930Uploaded 02-07-2024
    Access via NCI by Request
    Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    January 2014
    NCT00770809Uploaded 02-02-2024
    Access via NCI by Request
    Randomized Phase III Trial of Paclitaxel +Trastuzumab + Lapatinib Versus Paclitaxel + Trastuzumab as Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    September 2017
    NCT00557193Uploaded 01-12-2024
    Access via NCI by Request
    A Phase III Study of Risk Directed Therapy for Infants With Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; NSC#617807)
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    May 2020
    NCT02115282Uploaded 11-30-2023
    Access via NCI by Request
    A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    May 2021
    NCT01809691Uploaded 11-04-2023
    Access via NCI by Request
    A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
    Type(s) of Cancer
    Fatigue
    Study Phase
    Phase 3
    Study Completion Date
    May 2019
    NCT01781468Uploaded 10-21-2023
    Access via NCI by Request
    A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
    Type(s) of Cancer
    Bladder
    Study Phase
    Phase 3
    Study Completion Date
    November 2018
    NCT00942331Uploaded 10-11-2023
    Access via NCI by Request
    A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    October 2020
    NCT02339740Uploaded 09-28-2023
    Access via NCI by Request
    A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
    Type(s) of Cancer
    Neuroblastoma
    Study Phase
    Phase 3
    Study Completion Date
    March 2016
    NCT00085735Uploaded 09-23-2023
    Access via NCI by Request
    A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
    Type(s) of Cancer
    Sarcoma
    Study Phase
    Phase 3
    Study Completion Date
    March 2020
    NCT01231906Uploaded 08-18-2023
    Access via NCI by Request
    A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma
    Type(s) of Cancer
    Breast, Multiple Myeloma, Prostate
    Study Phase
    Phase 3
    Study Completion Date
    June 2014
    NCT00869206Uploaded 07-27-2023
    Access via NCI by Request
    A Randomized, Phase III Study of Standard Dosing Versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer
    Type(s) of Cancer
    Breast
    Study Phase
    Not Applicable
    Study Completion Date
    December 2019
    NCT01242800Uploaded 05-13-2023
    Access via NCI by Request
    A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients With Metastatic Breast Cancer
    Type(s) of Cancer
    Esophageal,Gastrointestinal
    Study Phase
    Phase 3
    Study Completion Date
    December 2019
    NCT01196390Uploaded 05-02-2023
    Access via NCI by Request
    A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma
    Type(s) of Cancer
    Multiple Myeloma
    Study Phase
    Phase 3
    Study Completion Date
    November 2025
    NCT01863550Uploaded 04-28-2023
    Access via NCI by Request
    Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
    Type(s) of Cancer
    COVID 19 Effect on Cancer Treatment
    Study Phase
    Study Completion Date
    March 2024
    NCT04387656Uploaded 04-19-2023
    Access via NCI by Request
    NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 1Phase 2
    Study Completion Date
    December 2016
    NCT01642251Uploaded 04-18-2023
    Access via NCI by Request
    Phase I and Randomized Phase II Double Blind Clinical Trial of Cisplatin and Etoposide in Combination With Veliparib (ABT-888) or Placebo as Frontline Therapy for Extensive Stage Small Cell Lung Cancer
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 1Phase 2
    Study Completion Date
    December 2018
    NCT02642965Uploaded 04-15-2023
    Access via NCI by Request
    A Phase 1/2 Study of CPX-351 (NSC# 775341) Alone Followed by Fludarabine, Cytarabine, and G-CSF (FLAG) for Children With Relapsed Acute Myeloid Leukemia (AML)
    Type(s) of Cancer
    Multiple Myeloma
    Study Phase
    Phase 3
    Study Completion Date
    January 2019
    NCT01169337Uploaded 04-01-2023
    Access via NCI by Request
    Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    October 2018
    NCT02048813Uploaded 03-31-2023
    Access via NCI by Request
    A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 1Phase 2
    Study Completion Date
    June 2013
    NCT00453154Uploaded 03-30-2023
    Access via NCI by Request
    Combination Chemotherapy With or Without Maintenance Sunitinib Malate (NSC 736511) for Untreated Extensive Stage Small Cell Lung Cancer: A Phase IB/Randomized Phase II Study
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    June 2024
    NCT02521493Uploaded 03-29-2023
    Access via NCI by Request
    Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    December 2019
    NCT02785952Uploaded 03-25-2023
    Access via NCI by Request
    A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer and No Matching Biomarker (Lung-Map Sub-Study)
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    November 2017
    NCT01238172Uploaded 03-17-2023
    Access via NCI by Request
    The Men's Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    January 2019
    NCT01107626Uploaded 03-15-2023
    Access via NCI by Request
    Randomized Phase III Study of Maintenance Therapy With Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
    Type(s) of Cancer
    Geriatric Cancer Communication
    Study Phase
    Not Applicable
    Study Completion Date
    May 2017
    NCT02107443Uploaded 02-14-2023
    Access via NCI by Request
    Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    October 2018
    NCT00430183Uploaded 02-07-2023
    Access via NCI by Request
    A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 2
    Study Completion Date
    August 2014
    NCT00861705Uploaded 01-07-2023
    Access via NCI by Request
    Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer
    Type(s) of Cancer
    Joint Pain
    Study Phase
    Phase 3
    Study Completion Date
    February 2018
    NCT01573442Uploaded 11-17-2022
    Access via NCI by Request
    Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias
    Type(s) of Cancer
    Liver
    Study Phase
    Phase 3
    Study Completion Date
    May 2015
    NCT01015833Uploaded 10-21-2022
    Access via NCI by Request
    Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    December 2006
    NCT00002920Uploaded 10-20-2022
    Access via NCI by Request
    A Randomized Comparison Of Medroxyprogesterone Acetate (MA) And Observation For Prevention Of Endometrial Pathology In Postmenopausal Breast Cancer Patients Treated With Tamoxifen, Phase III
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    December 2012
    NCT01099449Uploaded 10-18-2022
    Access via NCI by Request
    A Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium in Two Different Versions to Prevent Oxaliplatin-Induced Sensory Neurotoxicity
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    December 2013
    NCT00785291Uploaded 09-30-2022
    Access via NCI by Request
    A Randomized Phase III Trial of Weekly Paclitaxel Compared to Weekly Nanoparticle Albumin Bound Nab-paclitaxel or Ixabepilone With or Without Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    April 2021
    NCT02445391Uploaded 09-23-2022
    Access via NCI by Request
    A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
    Type(s) of Cancer
    CNS
    Study Phase
    Phase 3
    Study Completion Date
    August 2016
    NCT01372774Uploaded 09-14-2022
    Access via NCI by Request
    A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared With Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease
    Type(s) of Cancer
    CNS
    Study Phase
    Phase 3
    Study Completion Date
    October 2014
    NCT00377156Uploaded 09-13-2022
    Access via NCI by Request
    Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in Patients With One to Three Cerebral Metastases
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    February 2020
    NCT01150045Uploaded 02-19-2022
    Access via NCI by Request
    A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    April 2014
    NCT00288080Uploaded 02-03-2022
    Access via NCI by Request
    A Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT Vs AS and 3DCTR/IMRT Followed by Chemotherapy With Docetaxel and Prednisone for Localized, High-Risk, Prostate Cancer
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    April 2012
    NCT00041119Uploaded 12-31-2021
    Access via NCI by Request
    Cyclophosphamide And Doxorubicin (CA) (4 VS 6 Cycles) Versus Paclitaxel (4 VS 6 Cycles) As Adjuvant Therapy For Breast Cancer in Women With 0-3 Positive Axillary Lymph Nodes:A 2X2 Factorial Phase III Randomized Study
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    February 2016
    NCT00134056Uploaded 10-09-2021
    Access via NCI by Request
    Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer
    Type(s) of Cancer
    Prostate
    Real World Data
    Completion Date
    2017
    Uploaded 09-01-2021
    Available for Download
    Intermittent hormonal therapy of prostate cancer patients in Spain: a prevalence study
    Type(s) of Cancer
    Breast, Gynecological
    Study Phase
    Phase 3
    Study Completion Date
    August 2013
    NCT01376349Uploaded 08-21-2021
    Access via NCI by Request
    Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
    Type(s) of Cancer
    Sarcoma
    Study Phase
    Phase 3
    Study Completion Date
    September 2014
    NCT00346164Uploaded 08-12-2021
    Access via NCI by Request
    Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    August 2016
    NCT00382070Uploaded 08-11-2021
    Access via NCI by Request
    A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
    Type(s) of Cancer
    Gastrointestinal, Lung, Palliative Care
    Study Phase
    Phase 3
    Study Completion Date
    July 2017
    NCT02349412Uploaded 07-23-2021
    Access via NCI by Request
    Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
    Type(s) of Cancer
    Nasopharyngeal
    Study Phase
    Phase 3
    Study Completion Date
    December 2014
    NCT00274937Uploaded 07-09-2021
    Access via NCI by Request
    Treatment of Childhood Nasopharyngeal Carcinoma With Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy: A Groupwide Phase III Study
    Type(s) of Cancer
    Breast
    Study Phase
    Not Applicable
    Study Completion Date
    June 2017
    NCT01535066Uploaded 06-19-2021
    Access via NCI by Request
    Randomized Blinded Sham- and Waitlist-Controlled Trial of Acupuncture for Joint Symptoms Related to Aromatase Inhibitors in Women With Early Stage Breast Cancer
    Type(s) of Cancer
    Bacterial Infection
    Study Phase
    Phase 3
    Study Completion Date
    March 2019
    NCT01817075Uploaded 06-19-2021
    Access via NCI by Request
    Impact of Cleansing With Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children With Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT)
    Type(s) of Cancer
    Eye
    Study Phase
    Phase 3
    Study Completion Date
    February 2013
    NCT00072384Uploaded 06-08-2021
    Access via NCI by Request
    A Single Arm Trial of Systemic And Subtenon Chemotherapy For Groups C And D Intraocular Retinoblastoma
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    August 2017
    NCT00946712Uploaded 06-05-2021
    Access via NCI by Request
    A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    December 2017
    NCT00127205Uploaded 06-04-2021
    Access via NCI by Request
    Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer
    Type(s) of Cancer
    CNS
    Study Phase
    Phase 3
    Study Completion Date
    April 2018
    NCT02360215Uploaded 05-12-2021
    Access via NCI by Request
    A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    April 2015
    NCT00303628Uploaded 05-04-2021
    Access via NCI by Request
    Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients With Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    December 2022
    NCT02883049Uploaded 04-27-2021
    Access via NCI by Request
    A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
    Type(s) of Cancer
    Desmoid Fibromatosis
    Study Phase
    Phase 3
    Study Completion Date
    July 2019
    NCT02066181Uploaded 04-14-2021
    Access via NCI by Request
    A Phase III, Double Blind, Randomized, Placebo-Controlled Trial of Sorafenib in Desmoid Tumors or Aggressive Fibromatosis (DT/DF)
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    December 2013
    NCT00103285Uploaded 04-09-2021
    Access via NCI by Request
    Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL)
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    March 2012
    NCT00302003Uploaded 03-27-2021
    Access via NCI by Request
    A Phase III Study for the Treatment of Children and Adolescents With Newly Diagnosed Low Risk Hodgkin Disease
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    June 2018
    NCT01307579Uploaded 03-26-2021
    Access via NCI by Request
    A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    August 2013
    NCT00372593Uploaded 03-24-2021
    Access via NCI by Request
    A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg) Combined With Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults
    Type(s) of Cancer
    Leukemia/Lymphoma,Sarcoma
    Study Phase
    Phase 3
    Study Completion Date
    March 2019
    NCT01371981Uploaded 03-24-2021
    Access via NCI by Request
    A Phase III Randomized Trial for Patients With De Novo AML Using Bortezomib and Sorafenib (NSC# 681239, NSC# 724772) for Patients With High Allelic Ratio FLT3/ITD
    Type(s) of Cancer
    Cancer prevention
    Study Phase
    Phase 3
    Study Completion Date
    November 2018
    NCT01169259Uploaded 03-19-2021
    Available for Download
    Vitamin D and Omega-3 Trial (VITAL)
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    August 2013
    NCT00058474Uploaded 03-02-2021
    Access via NCI by Request
    A Clinical Trial Comparing Preoperative Radiation Therapy And Capecitabine With or Without Oxaliplatin With Preoperative Radiation Therapy And Continuous Intravenous Infusion Of 5-Fluorouracil With or Without Oxaliplatin In The Treatment Of Patients With Operable Carcinoma Of The Rectum
    Type(s) of Cancer
    Kidney
    Study Phase
    Phase 3
    Study Completion Date
    June 2002
    NCT00002611Uploaded 02-24-2021
    Access via NCI by Request
    NATIONAL WILMS TUMOR STUDY-5 -- THERAPEUTIC TRIAL AND BIOLOGY STUDY
    Type(s) of Cancer
    Eye
    Study Phase
    Phase 3
    Study Completion Date
    September 2011
    NCT00335738Uploaded 02-16-2021
    Access via NCI by Request
    A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy
    Type(s) of Cancer
    Oral Mucositis
    Study Phase
    Phase 3
    Study Completion Date
    May 2016
    NCT02229539Uploaded 02-10-2021
    Access via NCI by Request
    A Phase III Placebo-Controlled, Randomized Three-Arm Study of Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
    Type(s) of Cancer
    Sarcoma
    Study Phase
    Phase 3
    Study Completion Date
    September 2016
    NCT00653068Uploaded 01-29-2021
    Access via NCI by Request
    Treatment of Atypical Teratoid/Rhabdoid Tumors (AT/RT) of the Central Nervous System With Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation
    Type(s) of Cancer
    Clinical Trial Education
    Study Phase
    Not Applicable
    Study Completion Date
    August 2016
    NCT02054715Uploaded 01-23-2021
    Access via NCI by Request
    Evaluation of Psychoeducation for Cancer Patients Eligible for Clinical Trials
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    September 2017
    NCT00408005Uploaded 01-06-2021
    Access via NCI by Request
    Intensified Methotrexate, Nelarabine (Compound 506U78) and Augmented BFM Therapy for Children and Young Adults With Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) or T-cell Lymphoblastic Lymphoma
    Type(s) of Cancer
    Pancreas
    Study Phase
    Phase 2B
    Study Completion Date
    December 2013
    NCT01016483Uploaded 12-16-2020
    Available for Download
    Phase II Randomized Trial of MEK Inhibitor MSC1936369B or Placebo Combined With Gemcitabine in Metastatic Pancreas Cancer Subjects
    Type(s) of Cancer
    CNS
    Study Phase
    Phase 2B
    Study Completion Date
    February 2013
    NCT00813943Uploaded 12-15-2020
    Available for Download
    Cilengitide in Subjects With Newly Diagnosed Glioblastoma and Unmethylated MGMT Gene Promoter - a Multicenter, Open-label Phase II Study, Investigating Two Cilengitide Regimens in Combination With Standard Treatment (Temozolomide With Concomitant Radiation Therapy, Followed by Temozolomide Maintenance Therapy). [The CORE Study]
    Type(s) of Cancer
    CNS
    Study Phase
    Phase 3
    Study Completion Date
    November 2012
    NCT00689221Uploaded 12-15-2020
    Available for Download
    Cilengitide for Subjects With Newly Diagnosed Glioblastoma and Methylated MGMT Gene Promoter - A Multicenter, Open-label, Controlled Phase III Study, Testing Cilengitide in Combination With Standard Treatment (Temozolomide With Concomitant Radiation Therapy, Followed by Temozolomide Maintenance Therapy) Versus Standard Treatment Alone (CENTRIC)
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 2
    Study Completion Date
    November 2016
    NCT00887159Uploaded 12-11-2020
    Access via NCI by Request
    A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Small Cell Lung Cancer
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    2009
    N/AUploaded 12-07-2020
    Available for Download
    Randomized, Open-Label, Phase 3 Study of Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer of Nonsquamous Histology
    Type(s) of Cancer
    Leukemia/Lymphoma, Stem Cell Transplants
    Study Phase
    Phase 3
    Study Completion Date
    June 2017
    NCT01371656Uploaded 11-24-2020
    Access via NCI by Request
    A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
    Type(s) of Cancer
    Sarcoma
    Study Phase
    Phase 3
    Study Completion Date
    August 2012
    NCT00075582Uploaded 11-11-2020
    Access via NCI by Request
    Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients With Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 2B
    Study Completion Date
    July 2017
    NCT02499770Uploaded 11-05-2020
    Available for Download
    Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Etoposide and Carboplatin
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 2B
    Study Completion Date
    September 2018
    NCT02514447Uploaded 11-05-2020
    Available for Download
    Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients With Previously Treated Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Topotecan Chemotherapy
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 2B
    Study Completion Date
    August 2018
    NCT03041311Uploaded 11-05-2020
    Available for Download
    Phase 2 Study of Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib in Patients With Untreated Extensive-Stage Small Cell Lung Cancer (SCLC)
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    October 2017
    NCT00118209Uploaded 10-31-2020
    Access via NCI by Request
    Phase III Randomized Study of R-CHOP V. Dose-Adjusted EPOCH-R With Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas
    Type(s) of Cancer
    Sarcoma
    Study Phase
    Phase 3
    Study Completion Date
    December 2014
    NCT00354835Uploaded 10-06-2020
    Access via NCI by Request
    Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan (VI) for Patients With Intermediate-Risk Rhabdomyosarcoma (RMS)
    Type(s) of Cancer
    Pancreas
    Study Phase
    Phase 2BPhase 3
    Study Completion Date
    November 2012
    NCT01124786Uploaded 10-02-2020
    Available for Download
    A Phase II Randomized, Open-Label, Multicenter Study Comparing CO-1.01 With Gemcitabine as First-Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma
    Type(s) of Cancer
    Neuroblastoma
    Study Phase
    Phase 3
    Study Completion Date
    December 2013
    NCT00033293Uploaded 09-30-2020
    Access via NCI by Request
    A Phase III Randomized Trial of Intravenous Gammaglobulin Therapy for Patients With Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated With Chemotherapy and Prednisone
    Type(s) of Cancer
    Neuroblastoma
    Study Phase
    Phase 3
    Study Completion Date
    February 2015
    NCT00567567Uploaded 09-29-2020
    Access via NCI by Request
    Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
    Type(s) of Cancer
    Kidney
    Study Phase
    Phase 3
    Study Completion Date
    December 2014
    NCT00352534Uploaded 09-24-2020
    Access via NCI by Request
    Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
    Type(s) of Cancer
    Neuroblastoma
    Study Phase
    Phase 3
    Study Completion Date
    December 2013
    NCT01041638Uploaded 09-23-2020
    Access via NCI by Request
    A Comprehensive Safety Trial of Chimeric Antibody 14.18 (Ch14.18) With GM-CSF, IL-2 and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy
    Type(s) of Cancer
    Neuroblastoma
    Study Phase
    Phase 3
    Study Completion Date
    June 2014
    NCT00499616Uploaded 09-15-2020
    Access via NCI by Request
    Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma
    Type(s) of Cancer
    Esophageal
    Study Phase
    Phase 3
    Study Completion Date
    April 2015
    NCT00655876Uploaded 09-02-2020
    Access via NCI by Request
    A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Who Are Treated Without Surgery
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    March 2012
    NCT01026220Uploaded 09-02-2020
    Access via NCI by Request
    A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
    Type(s) of Cancer
    Uterine
    Study Phase
    Phase 3
    Study Completion Date
    September 2015
    NCT01012297Uploaded 08-21-2020
    Access via NCI by Request
    A Randomized Phase III Evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Bevacizumab (NSC #704865) Versus Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Placebo in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus
    Type(s) of Cancer
    Breast,Lung,Prostate
    Study Phase
    Phase 3
    Study Completion Date
    January 2012
    NCT00365105Uploaded 07-24-2020
    Access via NCI by Request
    Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    May 2011
    NCT00617669Uploaded 07-16-2020
    Available for Download
    A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 10 mg ZD4054 (Zibotentan) in Combination With Docetaxel in Comparison With Docetaxel in Patients With Metastatic Hormone-resistant Prostate Cancer
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    December 2008
    NCT00143455Uploaded 06-29-2020
    Available for Download
    Open Label, Randomised Multicentre Phase III Study Of Irinotecan Hydrochloride (Campto (Registered)) And Cisplatin Versus Etoposide And Cisplatin In Chemotherapy Naive Patients With Extensive Disease - Small Cell Lung Cancer
    Type(s) of Cancer
    Uterine
    Study Phase
    Phase 3
    Study Completion Date
    December 2015
    NCT01672892Uploaded 06-17-2020
    Access via NCI by Request
    A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    July 2010
    NCT00554229Uploaded 06-09-2020
    Available for Download
    Enhancing the Analytic Capacity of Prostat_AstraZe_2009_144 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
    Type(s) of Cancer
    Esophageal
    Study Phase
    Phase 3
    Study Completion Date
    March 2012
    NCT00678535Uploaded 05-18-2020
    Available for Download
    Enhancing the Analytic Capacity of Gastric_MerckKG_2008_130 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
    Type(s) of Cancer
    Esophageal
    Study Phase
    Phase 2BPhase 3
    Study Completion Date
    April 2012
    NCT00409188Uploaded 05-18-2020
    Available for Download
    Enhancing the Analytic Capacity of Gastric_SanofiU_1999_143 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    September 2006
    NCT00081796Uploaded 05-15-2020
    Available for Download
    Enhancing the Analytic Capacity of Breast_SanofiU_2004_135 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
    Type(s) of Cancer
    Liver
    Study Phase
    Phase 3
    Study Completion Date
    June 2020
    NCT00980460Uploaded 04-29-2020
    Access via NCI by Request
    Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    January 2011
    NCT00626548Uploaded 04-28-2020
    Available for Download
    Enhancing the Analytic Capacity of Prostat_AstraZe_2008_103 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    November 2012
    NCT00079274Uploaded 04-28-2020
    Access via NCI by Request
    A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    January 2017
    NCT01041781Uploaded 04-28-2020
    Access via NCI by Request
    A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    July 2016
    NCT00651261Uploaded 04-28-2020
    Access via NCI by Request
    A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)
    Type(s) of Cancer
    Germ Cell
    Study Phase
    Phase 3
    Study Completion Date
    October 2013
    NCT00053352Uploaded 04-28-2020
    Access via NCI by Request
    A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
    Type(s) of Cancer
    Eye
    Study Phase
    Phase 3
    Study Completion Date
    January 2010
    NCT00079417Uploaded 04-28-2020
    Access via NCI by Request
    Trial of Systemic Neoadjuvant Chemotherapy for Group B Intraocular Retinoblastoma
    Type(s) of Cancer
    Head and Neck
    Study Phase
    Phase 3
    Study Completion Date
    July 2018
    NCT01302834Uploaded 04-28-2020
    Access via NCI by Request
    Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer
    Type(s) of Cancer
    Esophageal
    Study Phase
    Phase 3
    Study Completion Date
    June 2012
    NCT00052910Uploaded 02-12-2020
    Access via NCI by Request
    Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    April 2015
    NCT02116530Uploaded 02-12-2020
    Access via NCI by Request
    Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Randomized, Double-Blind, Placebo-Controlled Trial
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    February 2015
    NCT00265850Uploaded 02-12-2020
    Access via NCI by Request
    A Phase III Trial of Irinotecan / 5-FU / Leucovorin or Oxaliplatin / 5-FU/ Leucovorin With Bevacizumab, or Cetuximab (C225), or With the Combination of Bevacizumab and Cetuximab for Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum
    Type(s) of Cancer
    Unspecified Adult Solid Tumor
    Study Phase
    Phase 3
    Study Completion Date
    December 2007
    NCT00081250Uploaded 02-12-2020
    Access via NCI by Request
    Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
    Type(s) of Cancer
    Uterine
    Study Phase
    Phase 3
    Study Completion Date
    June 2018
    NCT01533207Uploaded 02-12-2020
    Access via NCI by Request
    A Phase III Randomized Trial of Gemcitabine (NSC# 613327) Plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) Versus Observation for Uterus-Limited, High Grade Uterine Leiomyosarcoma
    Type(s) of Cancer
    Unspecified Adult Solid Tumor
    Study Phase
    Phase 3
    Study Completion Date
    July 2013
    NCT01198145Uploaded 02-09-2020
    Access via NCI by Request
    Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    June 2015
    NCT00866918Uploaded 02-09-2020
    Access via NCI by Request
    Risk Adapted Treatment of Newly Diagnosed Childhood Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide (Trisenox® ) During Consolidation
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    January 2014
    NCT00433511Uploaded 02-09-2020
    Access via NCI by Request
    A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    August 2018
    NCT01886872Uploaded 02-09-2020
    Access via NCI by Request
    A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (&gt;/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    June 2014
    NCT00601900Uploaded 01-18-2020
    Access via NCI by Request
    Endocrine Therapy With or Without Anti-VEGF Therapy: A Randomized, Phase III Trial of Endocrine Therapy Alone or Endocrine Therapy Plus Bevacizumab (NSC 704865) for Women With Hormone Receptor-Positive Advanced Breast Cancer
    Type(s) of Cancer
    Bladder
    Study Phase
    Phase 3
    Study Completion Date
    June 2017
    NCT00445601Uploaded 01-08-2020
    Access via NCI by Request
    A Phase III Blinded Study of Immediate Post TURBT Instillation of Gemcitabine Versus Saline in Patients With Newly Diagnosed or Occasionally Recurring Grade I/II Superficial Bladder Cancer
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    August 2017
    NCT00004124Uploaded 12-19-2019
    Access via NCI by Request
    Adjuvant Androgen Deprivation Versus Mitoxantrone Plus Prednisone Plus Androgen Deprivation in Selected High-Risk Prostate Cancer Patients Following Radical Prostatectomy
    Type(s) of Cancer
    CNS
    Study Phase
    Phase 3
    Study Completion Date
    July 2012
    NCT00369785Uploaded 12-18-2019
    Access via NCI by Request
    Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain
    Type(s) of Cancer
    Head and Neck
    Study Phase
    Phase 3
    Study Completion Date
    January 2011
    NCT00265941Uploaded 12-17-2019
    Access via NCI by Request
    A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin Versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) [Followed by Surgery for Selected Patients] for Stage III and IV Head and Neck Carcinomas
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 2B
    Study Completion Date
    October 2008
    NCT00301821Uploaded 09-11-2019
    Access via NCI by Request
    A Phase II Study of Epratuzumab, Rituximab (ER)-CHOP for Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
    Type(s) of Cancer
    Multiple Myeloma
    Study Phase
    Phase 3
    Study Completion Date
    July 2016
    NCT00644228Uploaded 08-21-2019
    Access via NCI by Request
    A Randomized Phase III Trial of CC-5013 (Lenalidomide, NSC-703813) and Low Dose Dexamethasone (LLD) Versus Bortezomib (PS-341, NSC-681239), Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction, in Patients With Previously Untreated Multiple Myeloma Without an Intent for Immediate Autologous Stem Cell Transplant
    Type(s) of Cancer
    Kidney
    Study Phase
    Phase 3
    Study Completion Date
    June 2016
    NCT00379340Uploaded 08-20-2019
    Access via NCI by Request
    Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    August 2009
    NCT00364013Uploaded 07-13-2019
    Available for Download
    A Randomized, Multicenter, Phase 3 Study to Compare the Efficacy of Panitumumab in Combination With Oxaliplatin/ 5-fluorouracil/ Leucovorin to the Efficacy of Oxaliplatin/ 5-fluorouracil/ Leucovorin Alone in Patients With Previously Untreated Metastatic Colorectal Cancer
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    October 2008
    NCT00113763Uploaded 07-13-2019
    Available for Download
    An Open-label, Randomized, Phase 3 Clinical Trial of ABX-EGF Plus Best Supportive Care Versus Best Supportive Care in Subjects With Metastatic Colorectal Cancer
    Type(s) of Cancer
    Kidney
    Study Phase
    Phase 3
    Study Completion Date
    December 2016
    NCT00945009Uploaded 07-10-2019
    Access via NCI by Request
    Treatment for Patients With Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor
    Type(s) of Cancer
    CNS
    Study Phase
    Phase 3
    Study Completion Date
    June 2019
    NCT00392327Uploaded 07-10-2019
    Access via NCI by Request
    Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients
    Type(s) of Cancer
    Sarcoma
    Study Phase
    Phase 3
    Study Completion Date
    January 2010
    NCT00354744Uploaded 05-25-2019
    Access via NCI by Request
    Intensive Multi-Agent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for Patients With High-Risk Rhabdomyosarcoma
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    January 2007
    NCT00003519Uploaded 04-26-2019
    Access via NCI by Request
    Phase III Study of Adriamycin/Taxotere Versus Adriamycin/Cytoxan for the Adjuvant Treatment of Node Positive or High Risk Node Negative Breast Cancer
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    March 2018
    NCT00310180Uploaded 04-24-2019
    Access via NCI by Request
    Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment:The TAILORx Trial
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    October 2015
    NCT00324805Uploaded 04-24-2019
    Access via NCI by Request
    A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (≥ 4 cm) - IIIA Non-small Cell Lung Cancer (NSCLC)
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 2B
    Study Completion Date
    January 2014
    NCT01439568Uploaded 01-23-2019
    Available for Download
    A Randomized Phase 2 Study of LY2510924 and Carboplatin/Etoposide Versus Carboplatin/Etoposide in Extensive-Stage Small Cell Lung Carcinoma
    Type(s) of Cancer
    Unspecified Adult Solid Tumor
    Study Phase
    Not Applicable
    Study Completion Date
    June 2010
    NCT00459134Uploaded 01-12-2019
    Access via NCI by Request
    A Randomized Study to Determine Whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors
    Type(s) of Cancer
    CNS
    Study Phase
    Phase 3
    Study Completion Date
    March 1994
    NCT03722355Uploaded 01-04-2019
    Access via NCI by Request
    A Phase III Comparison of Hyperfractionated Radiation Therapy (RT) With BCNU and Conventional RT With BCNU for Supratentorial Malignant Glioma
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    November 2013
    NCT00693992Uploaded 12-15-2018
    Access via NCI by Request
    Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511) as Maintenance Therapy in Non-progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB / IV Non-small Cell Lung Cancer
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    April 2014
    NCT00033631Uploaded 12-15-2018
    Access via NCI by Request
    A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
    Type(s) of Cancer
    Leukemia/Lymphoma, Myelodysplastic Syndrome (MDS)
    Study Phase
    Phase 3
    Study Completion Date
    December 2013
    NCT00369317Uploaded 12-06-2018
    Access via NCI by Request
    The Treatment of Down Syndrome Children With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Under the Age of 4 Years
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    December 2015
    NCT00754845Uploaded 11-22-2018
    Access via NCI by Request
    A Double Blind Randomization to Letrozole or Placebo for Women Previously Diagnosed With Primary Breast Cancer Completing Five Years of Adjuvant Aromatase Inhibitor Either as Initial Therapy or After Tamoxifen (Including Those in The MA.17 Study)
    Type(s) of Cancer
    Melanoma
    Study Phase
    Phase 3
    Study Completion Date
    October 2012
    NCT01989572Uploaded 10-31-2018
    Access via NCI by Request
    A Randomized, Placebo-Controlled Phase III Trial of Yeast Derived GM-CSF Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With "No Evidence of Disease" After Complete Surgical Resection of "Locally Advanced" and/or Stage IV Melanoma
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    June 2013
    NCT00981058Uploaded 10-16-2018
    Available for Download
    A Randomized, Multicenter, Open-Label Phase 3 Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Gemcitabine-Cisplatin Chemotherapy Alone in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    December 2016
    NCT01598298Uploaded 10-16-2018
    Access via NCI by Request
    A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer
    Type(s) of Cancer
    Leukemia/Lymphoma
    Study Phase
    Phase 3
    Study Completion Date
    September 2001
    NCT01230983Uploaded 09-15-2018
    Access via NCI by Request
    Intensive Treatment For T-CELL Acute Lymphoblastic Leukemia and Advanced Stage Lymphoblastic Non-Hodgkin's Lymphoma: A Pediatric Oncology Group Phase III Study
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    May 2007
    NCT00115765Uploaded 08-03-2018
    Available for Download
    PACCE: A Randomized, Open-Label, Controlled, Clinical Trial of Chemotherapy and Bevacizumab With and Without Panitumumab in the First-Line Treatment of Subjects With Metastatic Colorectal Cancer
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    April 2009
    NCT00339183Uploaded 08-03-2018
    Available for Download
    A Randomized, Multicenter Phase 3 Study to Compare the Efficacy of Panitumumab in Combination With Chemotherapy to the Efficacy of Chemotherapy Alone in Patients With Previously Treated Metastatic Colorectal Cancer
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    August 2009
    NCT00364013Uploaded 08-03-2018
    Available for Download
    A Randomized, Multicenter, Phase 3 Study to Compare the Efficacy of Panitumumab in Combination With Oxaliplatin/ 5-fluorouracil/ Leucovorin to the Efficacy of Oxaliplatin/ 5-fluorouracil/ Leucovorin Alone in Patients With Previously Untreated Metastatic Colorectal Cancer
    Type(s) of Cancer
    Head and Neck
    Study Phase
    Phase 3
    Study Completion Date
    May 2010
    NCT00460265Uploaded 08-03-2018
    Available for Download
    A Phase 3 Randomized Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    January 2007
    NCT00119613Uploaded 08-03-2018
    Available for Download
    A Randomized, Double Blind, Placebo-Controlled Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa
    Type(s) of Cancer
    Lung
    Study Phase
    Phase 3
    Study Completion Date
    June 2005
    NCT00003299Uploaded 07-30-2018
    Available for Download
    A Randomized Phase III Study Comparing Etoposide and Cisplatin With Etoposide, Cisplatin and Paclitaxel in Patients With Extensive Small Cell Lung Cancer
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    October 2004
    NCT00003594Uploaded 07-13-2018
    Access via NCI by Request
    A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients With Advanced Adenocarcinoma of the Colon and Rectum
    Type(s) of Cancer
    Breast
    Study Phase
    Phase 3
    Study Completion Date
    August 2007
    NCT00003855Uploaded 07-07-2018
    Access via NCI by Request
    A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
    Type(s) of Cancer
    Prostate
    Study Phase
    Phase 3
    Study Completion Date
    July 2012
    NCT00079001Uploaded 07-07-2018
    Access via NCI by Request
    A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone
    Type(s) of Cancer
    Head and Neck
    Study Phase
    Phase 3
    Study Completion Date
    January 1999
    NCT03370367Uploaded 07-07-2018
    Access via NCI by Request
    Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 2BPhase 3
    Study Completion Date
    November 2009
    NCT00384176Uploaded 07-02-2018
    Available for Download
    Enhancing the Analytic Capacity of Colorec_AstraZe_2006_78 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
    Type(s) of Cancer
    Colorectal
    Study Phase
    Phase 3
    Study Completion Date
    October 2013
    NCT00726622Uploaded 05-22-2018
    Access via NCI by Request
    A Phase III Prospective Randomized Trial Comparing Laparoscopic-Assisted Resection Versus Open Resection for Rectal Cancer
    Type(s) of Cancer
    Multiple Myeloma
    Study Phase
    Phase 3
    Study Completion Date
    January 2014
    NCT00602641Uploaded 03-06-2018
    Access via NCI by Request
    An Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide (MPT) Versus Melphalan, Prednisone and Lenalidomide (Revlimid(TM))(MPR) in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for High-Dose Therapy
    Type(s) of Cancer
    Neuroendocrine
    Study Phase
    Phase 3
    Study Completion Date
    January 2015
    NCT00569127Uploaded 02-24-2018
    Access via NCI by Request